dihexa peptide cream Triple Lipid-Peptide Dihexa Peptide Therapy | Cognitive

BPC-157 is not FDA approved for any therapeutic indication as of April 2026

Brattstrm L, Lindgren A, Israelsson B, Andersson A, and Hultberg B (1994)

While injection site lumps are generally benign and self-limiting, persistent or worsening symptoms warrant evaluation by a healthcare professional

The company built a real business on cheaper, pharmacy-mixed versions of Ozempic and Wegovy, then watched it get squeezed once the FDA declared the supply shortage over and later proposed excluding those drugs from the pharmacy compounding list ( a final decision has been pushed to July 30 )

Response speed varies considerably among individuals